Meet Our 2017 BEBPA Scientific Committee Members

The genesis of BEBPA came from a number of scientists from various companies, institutes and regulatory agencies. As our discussions matured we realized that despite the various venues for meetings and publication, there was no place for new approaches and ideas about common problems to be openly discussed and vetted without firms worrying that their comments would be taken as corporate policy. Each individual expressed the belief that something should be done about this – and that if something were done by the industry as a whole, then the individual companies involved would benefit immensely.

BEBPA provides an international forum for the presentation and discussion of scientific issues and problems encountered in the biopharmaceutical community. The aim of this open discussion is to promote development of innovative approaches and solutions thus facilitating safer and faster biopharmaceutical product development.

Scientific Committee Members

Jane Robinson

C. Jane Robinson, Ph.D., Consultant

Dr. C. Jane Robinson is a consultant in biopharmaceutical development, specializing in in-vitro bioassays and reference standards. Previously, she worked for 25 years at the National Institute for Biological Standards and Control (NIBSC), UK, where she established a laboratory for the testing and standardization of polypeptide growth factors of therapeutic and diagnostic potential. Dr. Robinson has advised regulatory authorities and other organizations on bioassay design and analysis, led collaborative projects to develop World Health Organization international standards and participated in the European Directorate for the Quality of Medicines and Healthcare (EDQM) testing of Centrally Approved Products. Dr. Robinson has lectured and provided training for regulatory, professional, academic and commercial organizations. She received her Ph.D. degree in chemistry from the Katholieke Universiteit te Leuven, Belgium in 1982.

LOCATION:
United Kingdom

TELEPHONE:
n/a

EMAIL ADDRESS:
Click Here

Stan Deming

Stan Deming, Ph.D, Statistical Designs

Stanley N. Deming, Ph.D. is president of Statistical Designs, El Paso, TX, through which he consults and offers short courses in the areas of experimental design, optimization, and the statistical analysis of laboratory data, with emphasis on bioassays. Dr. Deming received his B.A. degree in chemistry from Carleton College, Northfield, MN, and his M.S. and Ph.D. degrees in analytical chemistry from Purdue University, West Lafayette, IN. He has been on the chemistry department faculties of Emory University (1970-1974) and the University of Houston (1974-2001) where he is Professor Emeritus. Over his academic career, he was the major research advisor for 16 Ph.D. students and 19 M.S. students. Since 1975 he has taught (with Stephen L. Morgan) over 600 short courses.

Dr. Deming has been the author or co-author of approximately 100 papers and three books, including Experimental Design: A Chemometric Approach (Elsevier), Sequential Simplex Optimization: A Technique for Improving Quality and Productivity in Research, Development, and Manufacturing (CRC Press), and The 4PL: A Guide to the Use of the Four-Parameter Logistic Model in Bioassay (lulucom). He has served on the editorial boards of the Journal of Chemometrics (1987-2003), Critical Reviews in Analytical Chemistry (1996-2002), and Chemometrics and Intelligent Laboratory Systems (1987-1993). His web site is http://www.statisticaldesigns.com.

LOCATION:
El Paso, TX

TELEPHONE:
281-841-3992

EMAIL ADDRESS:
Click Here

Sian Esdale

Sian Estadale, Ph.D., Covance Laboratories Limited

Dr. Sian Estdale is Global Scientific Head of the Large Molecule Department of the BioPharm CMC Division at Covance.

LOCATION:
North Yorkshire, UK

TELEPHONE:
+44 (0) 1423 635438

EMAIL ADDRESS:
Click Here

Mike Merges

Mike Merges, Catalent Biologics

Mike Merges is Director of Strategic Growth at Catalent Biologics where he oversees the accelerated growth of Catalent’s Biologics Analytical Services spanning business development, technology innovations and technical advisory to Catalent’s network. Mike has 30 years of experience in cell biology, immunology and virology. He joined Catalent from Lonza Biologics where he was Associate Director of Bioservices. Prior to that, he was at the University of Maryland’s Institute of Human Virology, the National Cancer Institute and Johns Hopkins University. Mike received his MS in immunology from Hood College and his BS in microbiology from The Pennsylvania State University.

LOCATION:
Morrisville, NC

TELEPHONE:
919-809 4309

EMAIL ADDRESS:
Click Here

Michael Sadick

Mike Sadick, Ph.D., Catalent Biologics

Dr. Sadick is Principal Scientist at Catalent Biological Analytical Services, in Morrisville, NC., where he coordinates and oversees Bioassay, ELISA and Molecular Biology projects. Previously, he managed the Bioassay/Relative Potency team, for 10 years, at Catalent Biologics in Kansas City, MO (formerly Aptuit, Inc). Prior to that, Mike worked for 6 years at Eli Lilly and Co. as a Research Advisor leading the Bioassay Groups, Molecular Biology and Virology in support of Phase I-III projects, as well as providing guidance for commercial bioassay testing. Before his tenure at Eli Lilly, Dr. Sadick ran bioassay groups for 10 years at Genentech in South San Francisco. Dr. Sadick has an extensive background in cellular biology, cellular immunology and receptor signaling, molecular biology and biochemistry. He received his MS and Ph.D. in immunology from University of Washington in Seattle, and his BA in biology from Johns Hopkins, in Baltimore.

LOCATION:
Morrisville, NC

TELEPHONE:
919-465-85777

EMAIL ADDRESS:
Click Here